CD8+ cytotoxic T lymphocytes (CTLs) are the primary tumor-killing cells, which can activate themselves through T cell receptor binding to antigens presented by MHC-I molecules, expressing high levels of IFNγ, TNFα, perforin, and granzymes to kill tumor cells.129. The gene discussed is PRF1; the disease is neoplasm.